Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A pilot randomized controlled trial of ketamine in Borderline Personality Disorder
Sarah K. Fineberg, Esther Y. Choi, Rosa Shapiro-Thompson, et al.
Neuropsychopharmacology (2023) Vol. 48, Iss. 7, pp. 991-999
Closed Access | Times Cited: 19

Showing 19 citing articles:

Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms
John H. Krystal, Ege T. Kavalali, Lisa M. Monteggia
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 41-50
Open Access | Times Cited: 89
Psychiatric risks for worsened mental health after psychedelic use
Alessia Marrocu, Hannes Kettner, Brandon Weiss, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 3, pp. 225-235
Open Access | Times Cited: 18
Real world effectiveness of repeated ketamine infusions for treatment-resistant depression with comorbid borderline personality disorder
Kevork Danayan, Noah Chisamore, Nelson B. Rodrigues, et al.
Psychiatry Research (2023) Vol. 323, pp. 115133-115133
Closed Access | Times Cited: 18
Ketamine-Assisted Psychotherapy for Antisocial Personality Disorder: A Case Report
Matthew Hicks, Heather Zwickey, Ryan Bradley
Journal of Psychoactive Drugs (2025), pp. 1-7
Closed Access
Clinical trials since 2020 of rapid anti-suicidal ideation effects of ketamine and its enantiomers: a systematic review
Sumra Sajid, J. John Mann, Michael F. Grunebaum
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access
Prediction of individual treatment allocation between electroconvulsive therapy or ketamine using the Personalized Advantage Index
Benjamin Wade, Ryan Pindale, James Luccarelli, et al.
npj Digital Medicine (2025) Vol. 8, Iss. 1
Open Access
Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning‐Based Advanced Perspectives
Sung‐Hyun Kim, Sumin Yang, Jeehye Jung, et al.
Advanced Science (2025)
Open Access
Drug Treatment of other Psychiatric Conditions

(2025), pp. 787-802
Closed Access
Ketamine-Assisted Psychotherapy for Treatment of Co-occurring Borderline Personality Disorder and Depression: A Case Study
Albert Yeung, Michael Alpert, David Mischoulon
Journal of Personality Disorders (2025) Vol. 39, Iss. 2, pp. 170-184
Closed Access
Depression with comorbid borderline personality disorder - could ketamine be a treatment catalyst?
Magdalena Więdłocha, Piotr Marcinowicz, Jan Komarnicki, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
Very Low-Dose Sublingual Ketamine for Borderline Personality Disorder and Treatment-Resistant Depression
Mitchell B. Liester, Rachel Wilkenson, Barry Patterson, et al.
Cureus (2024)
Open Access | Times Cited: 1
Ketamine for the Treatment of Psychiatric Disorders: A Systematic Review and Meta-Analysis
Angela T.H. Kwan, Moiz Lakhani, Gurkaran Singh, et al.
CNS Spectrums (2024), pp. 1-8
Closed Access | Times Cited: 1
Advances in Management of Personality Disorders in a Residential Setting
Michael Young
Advances in Psychiatry and Behavioral Health (2024) Vol. 4, Iss. 1, pp. 147-155
Closed Access
Efficacy of single and repeated ketamine administration for suicidal ideation in adults with psychiatric disorders: A meta-analysis
Wanting Feng, Chengfeng Chen, Yexian Zeng, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 136, pp. 111152-111152
Closed Access
The impact of comorbid cluster B traits and personality disorders on depression treatment outcome: a systematic review and meta-analysis
Kevork Danayan, Jessica Newman, Katie Benitah, et al.
Nature Mental Health (2024) Vol. 2, Iss. 11, pp. 1392-1407
Closed Access
Tell Me About Yourself: Analyzing Self-Referential Language Use in Borderline Personality Disorder
Jan Welch, Wenjing Luo, Kyasha J Ambroise, et al.
Journal of Psychiatric Research (2024) Vol. 180, pp. 428-438
Closed Access
An in vivo examination of the relationship between metabotropic glutamate receptor 5 and suicide attempts in people with borderline personality disorder
Margaret T. Davis, Ruth Asch, Emily Weiss, et al.
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2024)
Closed Access
How to Mitigate Risk in the Treatment of Patients with Borderline Personality Disorder
Richard G. Hersh
Current Psychiatry Reports (2024)
Closed Access
New Frontiers in Ketamine Research: From Mechanisms of Action to Novel Psychiatric Treatment Approaches
Marcus C. Rosenhagen, Julien Elowe, Alberto Forte, et al.
American Journal of Psychiatry and Neuroscience (2023)
Open Access
Individual Prediction of Optimal Treatment Allocation Between Electroconvulsive Therapy or Ketamine using the Personalized Advantage Index
Benjamin Wade, Ryan Pindale, Joan A. Camprodon, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top